Biotech Startups

Clearmind Medicine is a clinical-stage biotech developing proprietary psychedelic-based treatments, with a focus on alcohol use disorder and related conditions. Its therapies are designed to be self-administered, and the company is publicly listed on the Nasdaq (CMND) and Frankfurt Stock Exchange (CWY0).

1 investor

ClearPoint Neuro develops neurosurgical guidance systems and platforms that enable precise navigation to the brain and spine for device, cell, and gene therapy procedures. The company serves neurosurgery centers and supports clinical drug delivery trials through live MRI-guided and image-guided technology.

1 investor

ClearSight Therapeutics develops over-the-counter ophthalmic products for common eye conditions such as dry eye, contact lens dryness, and conjunctivitis, working within FDA OTC monograph pathways. Its formulations aim to support ocular surface lubrication and moisture retention for consumers experiencing eye discomfort.

1 investor

Cleveland Diagnostics develops blood-based cancer diagnostic tests using its IsoClear platform, which measures structural changes in proteins to identify whether biomarkers came from cancer cells. Its first test, IsoPSA, targets prostate cancer detection to reduce unnecessary biopsies.

1 investor

Clever Leaves develops cannabis products and services across the supply chain, from raw materials to finished products, for licensed pharmaceutical companies seeking market access acceleration.

1 investor

ClicBio develops oral small-molecule CLIC1 inhibitors to treat metabolic diseases by modulating appetite through hypothalamic neuron regulation. The company targets obesity and metabolic disease through a mechanism that acts independently from and additively with GLP-1 agonists.

1 investor

Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.

1 investor

ClickBio manufactures laboratory automation hardware and reagent handling equipment for life sciences research, including reagent reservoirs, fill stations, and plate adapters compatible with standard microplate formats.

1 investor

ClimateCrop uses a non-GMO, targeted gene edit to increase transitory starch storage in plant leaves, improving photosynthetic efficiency to deliver higher yields and greater tolerance to drought and heat. Its technology is applicable across vascular plant species for food crops, animal feed, fiber, and biofuel without requiring changes to existing farming practices.

1 investor

Clinovo provides staff augmentation services for pharmaceutical and biotech sponsors, embedding specialized clinical research professionals such as CRAs, data managers, and regulatory specialists directly into sponsor teams on a flexible basis. The company serves clinical trial sponsors seeking to scale internal teams with regulated expertise without permanent hiring overhead.

1 investor

CLLEVERT develops laboratory instrumentation and diagnostic technology solutions, with expertise in biochemistry, materials science, and clinical diagnostics. The company transforms advanced research into practical laboratory equipment and methods for improved efficiency and sustainability.

1 investor

Clover Biopharma is a commercial-stage biotechnology company that develops vaccines using its Trimer-Tag technology platform along with in-house manufacturing and commercial capabilities. Its pipeline focuses on respiratory vaccine candidates, including RSV, hMPV, and PIV3 combinations, for populations worldwide.

1 investor

Cloverleaf Bio is developing engineered tRNA therapeutics for oncology, designed to inhibit multiple enzymes required for cancer growth from a single molecule. The company focuses on cancer treatment within the biotech and therapeutics space.

1 investor

Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.

1 investor

C&C International develops cosmetic and beauty products through dedicated makeup and skincare research laboratories, serving the beauty industry.

1 investor

Coastar Therapeutics develops gene delivery technologies using erythrocyte-derived membranes to enable genetic medicines for cancer immunotherapy and gene therapies. The company works with pharmaceutical and biotech partners to deliver therapeutics with improved immune evasion and precision targeting.

1 investor

Coastline Bio is a biopharmaceutical company developing novel medicines for immunological skin diseases, with an initial focus on atopic dermatitis. The company is developing a first-in-class monoclonal antibody targeting disease pathways in skin conditions.

1 investor

Cocuus develops production technology for the food industry, with a focus on meat processing, to create nutritious and sustainable food products.

1 investor

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver. The platform is designed for re-dosing, delivery of large gene constructs approaching 10kb, and modular manufacturing for genetic medicine development.

1 investor

Codexis provides enzyme engineering and biocatalysis services for RNA and small molecule API manufacturing, offering RNAi/siRNA and enzymatic synthesis solutions to pharmaceutical partners. It supports customers from process development through scalable commercial supply using an in-house pilot plant and CMO network.

1 investor

Cognigenics is developing iRNAi, a non-invasive intranasal RNA interference platform that delivers programmable RNA therapeutics directly to targeted brain circuits, bypassing the blood-brain barrier to modulate mood, memory, and cognition. The company focuses on precision neuropsychiatry and treatments for neurological and psychiatric disorders.

1 investor

Avacare Clinical Research Network operates a centralized clinical trial network that connects sponsors, research sites, and patients for clinical trials. It provides research-experienced investigators, data-driven operations, and site support tools, along with a patient platform for finding and enrolling in open studies.

1 investor

Coherence Bio makes Keystone, a benchtop laboratory instrument that integrates cell culture, fluid handling, scheduled interventions, and multimodal imaging into a single uninterrupted multi-day run. It is aimed at research labs running organoid, spheroid, and other multi-day cell biology protocols such as longitudinal phenotyping and drug response kinetics.

1 investor

Coherent Biopharma (Tongyi Pharmaceutical) is a biopharmaceutical company developing its proprietary Bi-targeting XDC (bi-XDC) conjugate drug platform to make previously undruggable targets treatable, with a focus on oncology. It has a pipeline of first-in-class candidates and clinical trials across multiple cancer indications, operating in China, the U.S., and Australia.

1 investor